We could not find any results for:
Make sure your spelling is correct or try broadening your search.
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024Phase 2a clinical trial of GH001 in postpartum...
DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and...
DUBLIN, Ireland, Nov. 09, 2023 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.72 | -6.41139804096 | 11.23 | 12.26 | 10.3 | 50035 | 11.20231562 | CS |
4 | -0.05 | -0.473484848485 | 10.56 | 12.26 | 10.3 | 100671 | 11.12293904 | CS |
12 | 2.71 | 34.7435897436 | 7.8 | 12.26 | 6.82 | 128670 | 9.58647308 | CS |
26 | 3.51 | 50.1428571429 | 7 | 12.26 | 5.05 | 113930 | 8.14466488 | CS |
52 | 2.69 | 34.3989769821 | 7.82 | 14.7 | 5.05 | 91420 | 9.24141831 | CS |
156 | -11.49 | -52.2272727273 | 22 | 30.43 | 5.05 | 87774 | 13.86300539 | CS |
260 | -11.49 | -52.2272727273 | 22 | 30.43 | 5.05 | 87774 | 13.86300539 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions